Table 1. Notch1 expression in human... | American Society of Hematology

Table 1.

Notch1 expression in human malignant B- and T-cell lymphoma entities

No. cases	Lymphoma entity	Notch1 protein expression^*			Epstein-Barr-virus^‡	ALK-protein^†
No. cases	Lymphoma entity	Absent	Weak	Strong	Epstein-Barr-virus^‡	ALK-protein^†
8	B-CLL^1-153	3	5	—	ND	ND
9	Mantle cell lymphoma	5	4	—	ND	ND
10	Follicle center lymphoma	2	8	—	ND	ND
8	Marginal zone B-cell lymphoma	3	5	—	ND	ND
10	Diffuse large B-cell lymphoma	—	10	—	ND	ND
8	Sporadic Burkitt lymphoma	—	8	—	—	ND
25	Classical HD	—	—	25	14	—
12	ALCL	—	—	12	—	9

No. cases	Lymphoma entity	Notch1 protein expression^*			Epstein-Barr-virus^‡	ALK-protein^†
No. cases	Lymphoma entity	Absent	Weak	Strong	Epstein-Barr-virus^‡	ALK-protein^†
8	B-CLL^1-153	3	5	—	ND	ND
9	Mantle cell lymphoma	5	4	—	ND	ND
10	Follicle center lymphoma	2	8	—	ND	ND
8	Marginal zone B-cell lymphoma	3	5	—	ND	ND
10	Diffuse large B-cell lymphoma	—	10	—	ND	ND
8	Sporadic Burkitt lymphoma	—	8	—	—	ND
25	Classical HD	—	—	25	14	—
12	ALCL	—	—	12	—	9

Rat monoclonal antibody against human Notch1.

Fusion of the nucleophosmin gene (NPM) to ALK.

Epstein-Barr virus–encoded RNA.

Patients with B-cell chronic lymphocytic leukemia. ND, not determined.